Novel MRI technique could reduce breast biopsies

October 2, 2012

Water diffusion measurements with MRI could decrease false-positive breast cancer results and reduce preventable biopsies, according to a new study published online in the journal Radiology. Researchers said the technique also could improve patient management by differentiating high-risk lesions requiring additional workup from other non-malignant subtypes.

Dynamic contrast-enhanced MRI (DCE-MRI) has emerged in recent years as a useful tool in detection and staging. One of its primary limitations is a substantial number of false-positive findings that require biopsies.

"Many benign lesions demonstrate enhancement on DCE-MRI," said Savannah C. Partridge, Ph.D., research associate professor at the University of Washington, Seattle Cancer Care Alliance. "We need another means for differentiating from malignancies."

One possible solution is diffusion-weighted imaging (DWI), an that calculates the apparent diffusion coefficient (ADC)—a measure of how water moves through tissue.

"DWI has been used mostly in neurological applications, but it's been studied more recently in breast imaging," Dr. Partridge said. "It only adds a couple of minutes to the MRI exam and does not require additional contrast or any extra hardware."

Research has shown that DWI is a promising tool for distinguishing between benign and malignant breast lesions. Normal has a high ADC because water moves through it relatively freely, while most cancers have a lower ADC because their cells are more tightly packed and restrict water motion. However, significant overlap exists between the ADC values of non- and breast malignancies, and little is known about the ADC values of specific subtypes of non-malignant lesions.

For the new study, Dr. Partridge and colleagues evaluated the DWI characteristics of non-malignant lesions in 165 women. Based on ADC values above a previously determined diagnostic threshold, DWI successfully characterized 46 percent of non- identified as false-positive findings on DCE-MRI as benign.

"We were excited to see the number of false positives that could be reduced through this approach," Dr. Partridge said. "DWI gives us extra microstructural information to distinguish among lesions. We can use ADC values to draw a cutoff above which we might not need to do a biopsy."

The research team is planning a multicenter trial to validate the findings and determine how to best to incorporate ADC measures into clinical breast MRI interpretations.

"We are very motivated to translate this promising technology to a clinically useful tool," Dr. Partridge said.

Explore further: MRI may be noninvasive method to measure breast cancer prognosis

Related Stories

MRI may be noninvasive method to measure breast cancer prognosis

December 8, 2011
Quantitative magnetic resonance imaging measures were associated with prognostic tumor markers, demonstrating the potential of magnetic resonance imaging for prediction of disease prognosis and stratification of patients ...

Recommended for you

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

Newest data links inflammation to chemo-brain

December 14, 2017
Inflammation in the blood plays a key role in "chemo-brain," according to a published pilot study that provides evidence for what scientists have long believed.

One in five young colon cancer patients have genetic link

December 13, 2017
As doctors grapple with increasing rates of colorectal cancers in young people, new research from the University of Michigan may offer some insight into how the disease developed and how to prevent further cancers. Researchers ...

New strategy for unleashing cancer-fighting power of p53 gene

December 13, 2017
Tumor protein p53 is one of the most critical determinants of the fate of cancer cells, as it can determine whether a cell lives or dies in response to stress. In a new study published today in the journal Nature Communications, ...

Researchers develop test that can diagnose two cancer types

December 12, 2017
A blood test using infrared spectroscopy can be used to diagnose two types of cancer, lymphoma and melanoma, according to a study led by Georgia State University.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.